导航菜单
From October 10 to 16, a total of four new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not yet been publicly disclosed.
Cyclization is a well-established strategy for improving peptide stability. Cyclic peptides have stable conformations and a certain degree of resistance to enzymatic degradation, while offering both affinity and mildness. This cyclic peptide is the sixth peptide-based new cosmetic ingredient filed by Zhejiang Peptites, with designated functions as an anti-wrinkle agent and skin protectant. Zhejiang Peptites is a leading company in China's cosmetic peptide industry.
Ficus hirta, commonly known in China as "Wuzhimaotao" (五指毛桃), is widely used as a soup ingredient in Guangdong, Guangxi, Hainan, and Fujian, where it is deeply rooted in local food culture. It also has a long history of use in traditional folk medicine. Studies have shown that its roots contain various bioactive compounds, including flavonoids, triterpenes, polysaccharides, and coumarins.
The notifier, Bai Yun Mei Wan Medical Beauty International Cosmetics Research Institute, was established in 2023 through a joint initiative of the People's Government of Baiyun District, Guangzhou, and Southern Medical University.
The same notifier has also filed Pholiota nameko Fruiting Body Extract (Notification No. 20260155) during the reporting period covered in this issue (October 10 - 16, 2026).
This ingredient is a derivative of Oryza Sativa (Rice) Germ Oil. The notifier, Hangzhou Jiajiale Biotechnology Co., Ltd., was established in 2020 and is a technology-driven company specializing in the development and application of biosynthesis technologies.
